Skip to main content
. 2022 Jan 31;7(1):e007662. doi: 10.1136/bmjgh-2021-007662

Table 5.

Grouped and cognitive AP studies and indicators

Study design Cohort Cross-sectional Mixed-methods Secondary cross-sectional Total
 N 0 17 1 6 24
 % 0% 71% 4% 25% 100%
Assessment approaches Clinical only Self-report only Functional only Clinical and self-report Clinical and functional Other combination Secondary sources (multiple)
 N 1 21 0 1 0 1 0 24
 % 4% 88% 0% 4% 0% 4% 0% 100%
Participants (N)* <500 500–999 1000–4999 5000–9999 10 000–24 999 >25 000 Not available
 N 0 3 7 5 5 4 0 24
 % 0% 13% 29% 21% 21% 17% 0% 100%
Age (years) included† Under 15 <15 to 85+ 15 to 85+ 40 to 85+ 60 to 85+ Over 85 Other
 N 0 16 5 0 2 0 1 24
 % 0% 67% 21% 8% 8% 0% 4% 100%
JBI score <7 7 8 9 10
 N

0 2 5 10 7 24
 % 0% 8% 21% 42% 29% 100%
Functioning difficulty or impairment definition Use of AP Reported activity limitations Clinical threshold Combination
 N 3 21 0 0 24
 % 13% 88% 0% 0% 100%
WHO Region AFR AMR EMR EUR SEAR WPR Global
 N 14 7 1 0 2 1 0 25
 % 56% 28% 4% 0% 8% 4% 0% 100%
AP access indicator Total need Met need Unmet need Undermet need Coverage Use Has AP
 N 2 4 9 1 0 24 2 42
 % 5% 10% 21% 2% 0% 57% 5% 100%
Indicator denominator Total with/using AP Total with need Total with functioning difficulty Total participants Total population
 N 1 5 28 8 0 42
 % 2% 12% 67% 19% 0% 100%

*Participants (N) ranged from 505 to 393 949 for this domain.

†Age group boundaries varied considerably by study; studies are sorted into categories that most closely represent their included age boundaries.

AFR, African Region; AMR, Region of the Americas; AP, assistive product; EMR, Eastern Mediterranean Region; EUR, European Region; JBI, Joanna Briggs Institute; SEAR, Southeast Asian Region; WPR, Western Pacific Region.